Literature DB >> 2587808

Clinical radiobiology of malignant melanoma.

S M Bentzen1, J Overgaard, H D Thames, M Overgaard, P Vejby Hansen, H von der Maase, J Meder.   

Abstract

Tumor-control probability (TCP) was analyzed in a series of 121 patients having 239 histologically proven recurrent or metastatic malignant melanomas. These were treated with fractionated radiotherapy with various doses per fraction, total doses, and overall times. Cutaneous lesions (127, 53%) were treated with electron beams, and more deeply seated tumors (112, 47%) with 60Co or 4-8 MV X-rays. The fraction size was highly variable, and this permitted determination of the alpha/beta ratio in the multifraction linear-quadratic model, which was estimated at 0.57 Gy with 95% confidence limits [-1.07, 2.5] Gy. Treatment time had no demonstrable influence on TCP. Thus this tumor exhibits the fractionation sensitivity characteristic of a late-responding normal tissue, suggesting that an adequate fractionation schedule for malignant melanomas would be characterized by larger-than-conventional doses per fraction, possibly about 6 Gy per fraction. This is consistent with the conclusions of other authors. Tumor size, evaluated as mean tumor diameter, S, had a major impact on TCP: the number of target cells increased as a power function of S with exponent 0.72 (95% confidence limits [0.49, 0.94]. In fact, a considerable amount of the heterogeneity in the dose-response data could be removed by accounting for size. Thus, the weak or absent dose response became highly significant. When a patient had multiple lesions, the responses of these to radiotherapy tended to be similar, thus implying that results were significantly influenced by a "hidden parameter" (such as inherent radiosensitivity or immunological status). A test of the predictive value of the TCP-model was performed in a different series of 183 cutaneous and lymph node malignant melanomas. The observed dose-response relationship in this data set was in good agreement with the model prediction. A chi-square test for goodness-of-fit showed that the variation between predicted and observed results could be explained by the binomial variation on quantal response data.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587808     DOI: 10.1016/0167-8140(89)90017-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  27 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 2.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

3.  [A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice].

Authors:  C Petersen; M Baumann; H H Dubben; H Arps; A Melenkeit; J Helfrich
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

Review 4.  The role of radiation therapy in the management of cutaneous melanoma.

Authors:  Charlene E Kan; David B Mansur
Journal:  Melanoma Manag       Date:  2016-02-24

5.  Anorectal melanoma.

Authors:  David Row; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 6.  The evolving role of radiation therapy in the management of malignant melanoma.

Authors:  Niloufer Khan; Mohammad K Khan; Alex Almasan; Arun D Singh; Roger Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

7.  Personal perspectives on the evolution of radiation therapy and future outlook for SRS.

Authors:  Ian Paddick
Journal:  J Radiosurg SBRT       Date:  2018

8.  Ferromagnetic hyperthermia in rabbit eyes using a new glass-ceramic thermoseed.

Authors:  M Matsumoto; N Yoshimura; Y Honda; M Hiraoka; K Ohura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-03       Impact factor: 3.117

9.  Anal melanoma.

Authors:  Marc Singer; Matthew G Mutch
Journal:  Clin Colon Rectal Surg       Date:  2006-05

10.  Prognostic value of tumor volume in nasopharyngeal carcinoma.

Authors:  Jeong-Hyun Kim; Joon-Kyoo Lee
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.